Health Care & Life Sciences » Biotechnology | Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB
Stock Exchange Frankfurt Stock Exchange
EPS
 EUR0.08
Market Cap
 EUR186.22 M
Shares Outstanding
 176.54 M
Public Float
 -
Oasmia Pharmaceutical AB ADR
Stock Exchange NASDAQ Stock Market
EPS
 $0.29
Market Cap
 $150.68 M
Shares Outstanding
 74.97 M
Public Float
 -
Oasmia Pharmaceutical AB
Stock Exchange OTC Publication Venue
EPS
 SEK0.87
Market Cap
 SEK1.53 B
Shares Outstanding
 224.9 M
Public Float
 132.86 M

Profile

Address
Vallongatan 1
Uppsala UP 752 28
Sweden
Employees -
Website http://www.oasmia.com
Updated 07/08/2019
Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Financials

View All
Created with Highcharts 5.0.14Oasmia Pharmaceutical ABNet Income. Fiscal year is May-April. All values SEK Thousands.105 112105 112117 497117 497141 539141 539160 243160 243118 007118 007171 020171 020201420152016201720182019050k100k150k200k
Created with Highcharts 5.0.14Oasmia Pharmaceutical ABSales/Revenue. Fiscal year is May-April. All values SEK Thousands.60602 0702 0706 3736 3731721723 1693 1691 9801 98020142015201620172018201902k4k6k8k

Julian Aleksov
Chairman
Alexander Kotsinas
Non-Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.